The Rochester Epidemiology Project:  Twenty Years of Studies from the Department of Psychiatry

Mark Frye, MD and J. Michael Bostwick, MD

Introduction

First Speaker

Mark Frye, MD, is a Professor and Chair Department of Psychiatry and Psychology Mayo Clinic and Director of the Mayo Clinic Depression Center. He received his medical degree from the University of Minnesota School of Medicine and completed his psychiatric training at the Resnick Neuropsychiatric Institute at the David Geffen School of Medicine at UCLA. He subsequently completed a research fellowship in the Biological Psychiatry Branch at the National Institute of Mental Health in Bethesda, Maryland. While at NIMH, his research focused on the neurobiology of depression and bipolar disorder.  From 1998 to 2006, he served as Director of the UCLA Bipolar Disorder Research Program. Dr. Frye’s current research centers on genomics, proteomics, and brain imaging of mood disorders and alcoholism. Dr. Frye and his team established the Mayo Clinic Individualized Medicine Biobank for Bipolar Disorder in an effort to identify and understand the underpinning mechanisms of bipolar disorders through genomic studies. He has received research support from the National Institute of Mental Health, National Institute on Alcohol Abuse and Alcoholism, Mayo Clinic's Samuel C. Johnson Genomics of Addiction Program, and Mayo Clinic Center for Individualized Medicine. This work is linked to the Mayo Clinic Depression Center which provides diagnostic consultation for patients with treatment resistant depression and bipolar disorder. He is an active author, publishing more than 250 peer-reviewed publications. In addition to his clinical and research activities, Dr. Frye is active in education. He holds full master’s faculty privileges in Clinical and Translational Sciences at Mayo Graduate School and has provided mentorship to many residents, research fellows and assistant professors.  Dr. Frye has received multiple honors and awards both as an educator and researcher, including the Mogens Schou Award for Education from the International Society for Bipolar Disorder, two Mayo Clinic Rome Mentorship Awards and the Gerald Klerman Senior Investigator Award from the Depression and Bipolar Support Alliance.  Dr. Frye is an editorial board member of Journal Affective Disorder, Bipolar Disorders, International Journal of Bipolar Disorders and World Journal of Psychiatry.

Second Speaker

J. Michael Bostwick, MD, is Professor of Psychiatry in the Mayo Clinic College of Medicine and Senior Associate Dean for Admissions at Mayo Medical School in Rochester, MN. He has published extensively on suicide epidemiology and prevention, medical marijuana, and numerous psychosomatic topics, and serves on editorial boards for two medical journals. He is an avid teacher at all levels of Mayo's medical school and psychiatry residency, and frequently collaborates with trainees on research and writing projects. He holds undergraduate degrees from Yale University and the University of Hawaii in Art History and Zoology respectively. He attended Brown University for medical school, but in the interim between college and medical school was a newspaper reporter for the Cape Cod Times.

Learning Objectives

1. Consider the range of potential clinical questions that can be investigated using the REP.
2. Explore the range of study designs that can be used to answer clinical questions in the REP.

Live webcast available at:  http://videos.mayo.edu/live
1 AMA PRA Category 1 Credit(s)™ hour is offered for watching this Webcast live.  Ethos will be implemented for all post presentation surveys.  To document your attendance, please text the code given at the presentation to 507-200-3010.  For questions, email rstpsychgr@mayo.edu

Accreditation Statement

In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Credit Statement(s)

AMA

The Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

APA

The Department of Psychiatry and Psychology at Mayo Clinic, Rochester, is approved by the American Psychological Association to sponsor continuing education credits for psychologists. The Department of Psychiatry and Psychology at Mayo Clinic, Rochester maintains responsibility for this program and its content.

Archived webcast available at: Psychiatry & Psychology Video Library

All participants MUST complete the evaluation in order to get CME or APA Credit.

1) Text the CODE announced at the session within 48 hours to (507) 200-3010

2) Login at ce.mayo.edu and go to My Account, My Courses, Registered Courses, click Session title and START to access the required Evaluation.

-or-

Click the START button on that session page.

3) Evaluation must be completed within 2 weeks.

TRANSCRIPT
Any credit or attendance awarded from this session will appear on your Transcript.

Disclosure Summary

As a provider accredited by Joint Accreditation Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science (Mayo Clinic School of CPD) must ensure balance, independence, objectivity and scientific rigor in its educational activities. Course Director(s), Planning Committee Members, Faculty, and all others who are in a position to control the content of this educational activity are required to disclose all relevant financial relationships with any commercial interest related to the subject matter of the educational activity. Safeguards against commercial bias have been put in place. Faculty also will disclose any off label and/or investigational use of pharmaceuticals or instruments discussed in their presentation. Disclosure of these relevant financial relationships will be published in activity materials so those participants in the activity may formulate their own judgments regarding the presentation.

Listed below are individuals with control of the content of this program who have disclosed…

Relevant financial relationship(s) with industry:

Mark Frye, MD, Mayo Clinic              

Grant Support - Assurex Health, Mayo Foundation, Myriad, NIAAA, NIMH, Pfizer
Consultant - Actify Neurotherapies, Allergan, Intra-Cellular Therapies, Inc., Janssen, Mitsubishi Tanabe Pharma Coporation, Myriad, Neuralstem Inc., Otsuka American Pharmaceutical, Sunovion, Takeda, Teva Pharmaceuticals 

No relevant financial relationship(s) with industry:

Joshua Baruth, MD, Julia Benjamin, PhD, Ewa Bieber, MD, Deniz Doruk Camsari, MD., Melissa Goldschmidt, APRN, CNP, Sohail Mohammad, MBBS, MPH, Charlene Nelson, Daniela Rakocevic, MD, Kate Zelic, PhD

Speaker:  J. Michael Bostwick, MD

References to off-label usage(s) of pharmaceuticals or instruments in their presentation:
None

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s) and staff, please go here to review disclosures.